Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 624

1.
2.

Glycoprotein N subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection.

Burkhardt C, Himmelein S, Britt W, Winkler T, Mach M.

J Gen Virol. 2009 Aug;90(Pt 8):1951-61. doi: 10.1099/vir.0.010967-0. Epub 2009 May 6.

PMID:
19420160
3.

Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization.

Endresz V, Kari L, Berencsi K, Kari C, Gyulai Z, Jeney C, Pincus S, Rodeck U, Méric C, Plotkin SA, Gönczöl E.

Vaccine. 1999 Jan;17(1):50-8.

PMID:
10078607
4.

Induction of neutralizing antibody against human cytomegalovirus (HCMV) with DNA-mediated immunization of HCMV glycoprotein B in mice.

Hwang ES, Kwon KB, Park JW, Kim DJ, Park CG, Cha CY.

Microbiol Immunol. 1999;43(3):307-10.

PMID:
10338203
5.

Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge.

Wang H, Yao Y, Huang C, Chen Q, Chen J, Chen Z.

Virol Sin. 2013 Jun;28(3):174-82. doi: 10.1007/s12250-013-3330-9. Epub 2013 May 24.

PMID:
23715998
6.

[Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].

Wang QH, Wang XJ, Hu S, Ge JY, Bu ZG.

Wei Sheng Wu Xue Bao. 2007 Aug;47(4):677-81. Chinese.

PMID:
17944371
7.

Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.

Wen Y, Monroe J, Linton C, Archer J, Beard CW, Barnett SW, Palladino G, Mason PW, Carfi A, Lilja AE.

Vaccine. 2014 Jun 24;32(30):3796-804. doi: 10.1016/j.vaccine.2014.05.004. Epub 2014 May 14.

PMID:
24837507
8.

Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response.

Shimamura M, Mach M, Britt WJ.

J Virol. 2006 May;80(9):4591-600.

PMID:
16611919
9.
10.
11.

Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.

Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, Porter KR, Kochel TJ, August TJ, Hayes CG, Murphy GS.

Virology. 2001 Nov 10;290(1):74-82.

PMID:
11883007
12.

DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.

Jiang Y, Xiao S, Fang L, Yu X, Song Y, Niu C, Chen H.

Vaccine. 2006 Apr 5;24(15):2869-79. Epub 2006 Jan 18.

PMID:
16446016
13.
14.

Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.

Fei-fei G, Jian W, Feng X, Li-ping S, Quan-yun S, Jin-ping Z, Pu-yan C, Pei-hong L.

Vaccine. 2008 Oct 16;26(44):5590-4. doi: 10.1016/j.vaccine.2008.07.104. Epub 2008 Aug 30.

PMID:
18761388
15.

Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.

Kropff B, Burkhardt C, Schott J, Nentwich J, Fisch T, Britt W, Mach M.

PLoS Pathog. 2012;8(10):e1002999. doi: 10.1371/journal.ppat.1002999. Epub 2012 Oct 25.

PMID:
23133379
16.

Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies.

Loomis RJ, Lilja AE, Monroe J, Balabanis KA, Brito LA, Palladino G, Franti M, Mandl CW, Barnett SW, Mason PW.

Vaccine. 2013 Jan 30;31(6):919-26. doi: 10.1016/j.vaccine.2012.12.009. Epub 2012 Dec 14.

PMID:
23246547
17.

DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus.

Gil A, Shen S, Coley S, Gibson L, Diamond DJ, Wang S, Lu S.

Hum Vaccin Immunother. 2013 Oct;9(10):2120-32. doi: 10.4161/hv.25750. Epub 2013 Jul 25.

PMID:
24051429
18.

Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.

Bhardwaj N, Heise MT, Ross TM.

PLoS Negl Trop Dis. 2010 Jun 22;4(6):e725. doi: 10.1371/journal.pntd.0000725.

PMID:
20582312
19.

Development of novel vaccine strategies against human cytomegalovirus infection based on subviral particles.

Pepperl-Klindworth S, Frankenberg N, Plachter B.

J Clin Virol. 2002 Aug;25 Suppl 2:S75-85.

PMID:
12361759
20.

Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus.

Fu TM, Wang D, Freed DC, Tang A, Li F, He X, Cole S, Dubey S, Finnefrock AC, ter Meulen J, Shiver JW, Casimiro DR.

Vaccine. 2012 Dec 14;30(52):7469-74. doi: 10.1016/j.vaccine.2012.10.053. Epub 2012 Oct 26.

PMID:
23107592

Supplemental Content

Support Center